Atlas Trials

Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC

Clinical trial NCT00787267 · TERMINATED

Trial details

NCT number
NCT00787267
Sponsor
Duke University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2008-09-01
Primary completion
2013-06-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.